Entry |
|
Name |
Familial male-limited precocious puberty; Familial testotoxicosis; Gonadotropin-independent familial sexual precocity |
Supergrp |
Precocious puberty [DS: H00937] |
Description |
Familial male-limited precocious puberty, also known as familial testotoxicosis is a form of isosexual precocious puberty in boys in which testosterone levels are elevated independent of changes in luteinizing hormone-releasing hormone and serum luteinizing hormone levels. Activating mutations in the human luteinizing hormone receptor (hLHR) have been described.
|
Category |
Endocrine disease
|
Brite |
Human diseases [BR:br08402]
Endocrine and metabolic diseases
Gonadal diseases
H02019 Familial male-limited precocious puberty
Human diseases in ICD-11 classification [BR:br08403]
05 Endocrine, nutritional or metabolic diseases
Endocrine diseases
Disorders of the gonadal hormone system
5A81 Testicular dysfunction or testosterone-related disorders
H02019 Familial male-limited precocious puberty
|
Pathway |
|
Network |
|
Element |
N00886 | Mutation-activated LHCGR to LHCGR-GNAS-PKA signaling pathway |
|
Gene |
|
Other DBs |
|
Reference |
|
Authors |
Laue L, Chan WY, Hsueh AJ, Kudo M, Hsu SY, Wu SM, Blomberg L, Cutler GB Jr |
Title |
Genetic heterogeneity of constitutively activating mutations of the human luteinizing hormone receptor in familial male-limited precocious puberty. |
Journal |
|
Reference |
|
Authors |
Liu G, Duranteau L, Carel JC, Monroe J, Doyle DA, Shenker A |
Title |
Leydig-cell tumors caused by an activating mutation of the gene encoding the luteinizing hormone receptor. |
Journal |
|
LinkDB |
|